4.7 Article

Chemo-, site-selective reduction of nitroarenes under blue-light, catalyst-free conditions

期刊

CHINESE CHEMICAL LETTERS
卷 33, 期 5, 页码 2420-2424

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cclet.2021.11.023

关键词

Nitroarenes; Selective; Reduction; Catalyst-free; Photoinduced; Transborylation

向作者/读者索取更多资源

A new tandem reaction involving photoinduced double hydrogen-atom transfer and deoxygenative transborylation has been developed for the chemo- and site-selective reduction of nitroarenes. The reaction proceeds under catalyst-free, room temperature conditions, and shows excellent yields. The use of isopropanol as a hydrogen donor and tetrahydroxydiboron as a deoxygenative reagent makes this method convenient and cost-effective. The reaction can tolerate a wide range of reducible functional groups and selectively reduces the nitro group at the electron-deficient site.
The tandem reaction of photoinduced double hydrogen-atom transfer and deoxygenative transborylation for chemo- and site-selective reduction of nitroarenes into aryl amines under catalyst-free, room temperature conditions was disclosed in excellent yields. In this reaction, isopropanol ((PrOH)-Pr-i) was used as hydrogen donor and tetrahydroxydiboron [B-2(OH)(4)] as deoxygenative reagent with green, cheap, and commercially available credentials. In particular, a wide range of reducible functional groups such as halogen (-Cl, -Br and even -I), alkenyl, alkynyl, aldehyde, ketone, carboxyl, and cyano are all tolerated. Moreover, the reaction preferentially reduces the nitro group at the electron-deficient site over another nitro group in the same molecule. A detailed mechanistic investigation in combination of experiments and theoretical calculations gave a reasonable explanation for the reaction pathway. (C) 2021 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据